Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive value of intratumor metabolic and heterogeneity parameters on [18F]FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma.

Japanese journal of radiology - 1 Feb 2023

Ni Ming, Wang Shicun, Liu Xin, Shi Qin, Zhu Xingxing, Zhang Yifan, Xie Qiang, Lv Weifu

Abstract excerpt

PURPOSE: This study aimed to investigate the value of metabolic and heterogeneity parameters of 2-deoxy-2[18F]fluoro-D-glucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) in predicting epidermal growth factor receptor (EGFR) mutations in patients with lung adenocarcinoma (ADC). MATERIALS AND METHODS: A retrospective analysis was performed on 157 patients with lung ADC between September...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorodeoxyglucose F18

Share to Lung Neoplasms

Share to Mutation

Share to Positron Emission Tomography Computed Tomography

Share to Prognosis

Source

Identifiers

PMID: 36219311
DOI: 10.1007/s11604-022-01347-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive value of intratumor metabolic and heterogeneity parameters on [18F]FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma.PMID 36219311Read ↗

Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer.Semantic proximity Read ↗

Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metricsSemantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutationsSemantic proximity Read ↗

The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting EGFR mutations.Semantic proximity Read ↗

[Evaluate the value of (18)F-FDG PET-CT imaging in predicting the mutationsin epidermal growth factor receptor in lung adenocarcinoma].Semantic proximity Read ↗

Primary metabolic tumor volume from 18F-FDG PET/CT associated with epidermal growth factor receptor mutation in lung adenocarcinoma patients.Semantic proximity Read ↗

Metabolic radiogenomics in lung cancer: associations between FDG PET image features and oncogenic signaling pathway alterations.Semantic proximity Read ↗

Correlation between 18F-FDG PET/CT intra-tumor metabolic heterogeneity parameters and KRAS mutation in colorectal cancer.Semantic proximity Read ↗

Prognostic significance of integrating total metabolic tumor volume and EGFR mutation status in patients with lung adenocarcinoma.Semantic proximity Read ↗

The role of metabolic tumor volume (MTV) measured by [18F] FDG PET/CT in predicting EGFR gene mutation status in non-small cell lung cancer.Semantic proximity Read ↗

Association between metabolic activity and molecular alterations in lung adenocarcinoma: Insights from 18F-FDG PET/CT.Semantic proximity Read ↗

Development of lung cancer risk prediction models based on F-18 FDG PET imagesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.